Delivery Order SPE2DB25D7068-SPE2DB25FTWZD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,666.01 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,912.48 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of September 10, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.06 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of June 20, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,594.26 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.35 to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Ciprofloxacin-Dexamethasone otic suspension (7.5ML). This non-competitive, firm fixed-price delivery order is scheduled for completion by June 13, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $1,139.94 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL). This firm fixed-price contract, which is not set-aside designated, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) with a ceiling value of $1,723.58. This competitively awarded, firm fixed-price delivery order is set to be completed by May 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,765.26 on June 6, 2025, for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5-milliliter units, with a completion date of June 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with a ceiling value of $1,592.69. This non-competitive, firm fixed price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTWZDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,765.26 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on June 9, 2025, with completion scheduled for June 10, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Conshohocken, Pennsylvania. As a primary vendor for military and veteran healthcare systems through the DLA Medical Supply Chain, the company maintains an extensive portfolio of delivery orders covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for the antibiotic-corticosteroid combination otic suspension exemplifies the company's role in fulfilling routine pharmaceutical supply requirements for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/9/25 |